2015年
Advanced Thymic Cancer Treated with Carboplatin and Paclitaxel in a Patient Undergoing Hemodialysis
INTERNAL MEDICINE
- 巻
- 54
- 号
- 1
- 開始ページ
- 55
- 終了ページ
- 58
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.2169/internalmedicine.54.3484
- 出版者・発行元
- JAPAN SOC INTERNAL MEDICINE
A 53-year-old man with an asymptomatic anterior mediastinal tumor undergoing hemodialysis was referred to our institution. He was diagnosed with thymic basaloid carcinoma based on the findings of a chest tomography-guided biopsy and successfully treated with carboplatin (300 mg/m(2)/day) and paclitaxel (200 mg/ m2/day) on day 1 for six three-week cycles. To our knowledge, this is the first report regarding the efficiency of a carboplatin dose-definition method based on the body surface area with paclitaxel in a hemodialysis patient. This report may therefore be useful for treating hemodialysis patients who are candidates for carboplatin and paclitaxel therapy.
- リンク情報
- ID情報
-
- DOI : 10.2169/internalmedicine.54.3484
- ISSN : 0918-2918
- eISSN : 1349-7235
- PubMed ID : 25742894
- Web of Science ID : WOS:000347451600010